Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELACESTRANT vs ELBASVIR\GRAZOPREVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELACESTRANT vs ELBASVIR\GRAZOPREVIR: Safety Overview

Metric ELACESTRANT ELBASVIR\GRAZOPREVIR
Total FAERS Reports 6,935 4,200
Deaths Reported 525 124
Death Rate 7.6% 3.0%
Hospitalizations 843 520
Average Patient Age 65.7 yrs 56.8 yrs
% Female Patients 99.1% 45.1%
FDA Approval Date Jan 27, 2023 N/A
Manufacturer Stemline Therapeutics, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A